Sheena Meredith

The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that it is again reviewing the neuropsychiatric risks attached to

This month, the European Medicines Agency (EMA) gave marketing authorization to bevacizumab -vikg (Lytenava, Outlook Therapeutics) for the treatment

Body-piercer Josephine Vest is one of the lucky ones – her endometriosis was picked up relatively quickly.

The first-in-class complement factor D inhibitor danicopan (Voydeya) has been approved by the European Commission as an add-on agent for certain patients with the rare disease paroxysmal nocturnal hemoglobinuria (PNH).

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) this week recommended new contraindications on the

Girls are catching up with and sometimes surpassing boys in terms of adolescent substance use, warned the authors of a new report detailing trends across several regions between 2018 and 2022.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) this week recommended new contraindications on the coadministration of the protease inhibitor atazanavir (Reyataz, Bristol-Myers Squibb) with antineoplastic agents encorafenib and ivosidenib (atazanavir may significantly increase blood levels and thus side effects), and with the anticonvulsants carbamazepine, phenobarbital, and phenytoin (which may decrease serum levels of atazanavir).

While we may know doulas as people who support women during pregnancy, childbirth, and the postpartum period , they are also playing an increasing role in supporting people at the end of life.